Chemistry:Ceralasertib
From HandWiki
Ceralasertib is an investigational new drug that is being evaluated for the treatment of cancer.[1] It is an ATR kinase inhibitor.[2]
References
- ↑ "Ceralasertib - AstraZeneca/University of Pennsylvania". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800039325.
- ↑ "Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes". International Journal of Molecular Sciences 25 (5): 2767. February 2024. doi:10.3390/ijms25052767. PMID 38474014.
 |  |
